Clinical utility of the ratio between circulating fibrinogen and fibrin (ogen) degradation products for evaluating coronary artery disease in type 2 diabetic patients

Chinese Medical Journal
Wei-Xin XiongRong Tao

Abstract

We investigated whether and to what extent the ratio between circulating fibrinogen (Fg) and its degradation products (FDP) reflects the severity of coronary artery disease (CAD) in type 2 diabetic patients. Plasma levels of Fg and FDP were determined, and Fg/FDP ratio was calculated in 344 consecutive patients with type 2 diabetes and chest pain on exertion undergoing coronary angiography. The severity of CAD was evaluated by the number of significant CAD (>50% luminal diameter narrowing) and Gensini score. Plasma Fg was higher, but Fg/FDP ratio was lower in patients with significant CAD (n = 255) compared with those without (n = 89), due to a disproportionate increase in FDP. Fg and FDP correlated positively, while Fg/FDP ratio negatively, with the number of diseased coronary arteries and the tertile of Gensini score (all P values for trend < 0.01). After adjusting for age, sex, risk factors for CAD, lipid profiles, glycosylated hemoglobin A1c, creatinine, leukocyte count, and high-sensitivity C-reactive protein, Fg/FDP ratio remained an independent determinant for multivessel coronary disease (MVD) (odds ratio [OR], 0.869; 95% confidence interval [CI], 0.788-0.958, P = 0.005) and high tertile of Gensini score (OR, 0.797, 95%...Continue Reading

References

Feb 1, 1983·The American Journal of Cardiology·G G Gensini
May 16, 2000·Diabetes Research and Clinical Practice·T YamadaK Hashizume
Oct 7, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·P E MorangeUNKNOWN AtheroGene Investigators
Jan 6, 2009·Diabetes Care·UNKNOWN American Diabetes Association
Nov 17, 2010·Journal of Thrombosis and Thrombolysis·Giuseppe De LucaUNKNOWN Novara Atherosclerosis Study Group (NAS)
Nov 29, 2012·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Fred J L M HaasCornelis Kluft
Jan 8, 2013·The American Journal of Cardiology·Gjin NdrepepaAdnan Kastrati
Oct 9, 2014·Blood Reviews·John C Chapin, Katherine A Hajjar

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass
sandwich immunoassay

Clinical Trials Mentioned

NCT02089360

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.